Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	19.81	-130.06	108.56
Graham Fair Price	72.59	6.18	3.58
PEG	15.16	0.10	-0.08
Price/Book	-9.60	2.79	3.09
Price/Cash Flow	99.44	-63.99	-11409.36
Prices/Earnings	-70.55	-39.99	135.80
Price/Sales	405.69	142.66	28.21
Price/FCF	99.44	-63.99	-11409.36
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.59	0.40	0.50
Operating Margin	3958.22	-0.91	0.02
ROA	207.91	-0.01	< 0.005
ROE	< 0.005	-0.02	206.99
ROIC	< 0.005	-0.02	235.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.86	-0.11	682.48
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.41	-8.13	138.38
EPS QOQ	16.31	-4.17	-74.43
FCF QOQ	-1.12	-157.41	-13985.36
Revenue QOQ	0.95	-0.82	-13.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	157.41	827.58	425.74
Days Sales Outstanding (DSO)	173.93	1007.71	479.37
Inventory Turnover	0.57	0.11	-80.98
Debt/Capitalization	< 0.005	0.01	87.70
Quick Ratio	3.25	3.24	-0.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.02	9.87	-1.50
Cash	5.63	5.12	-8.93
Capex	-0.25	-0.10	58.21
Free Cash Flow	< 0.005	-0.43	-15776.45
Revenue	1.10	0.19	-82.39
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.71	3.78	1.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-23.56	28.55	21.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating